BillionToOne Inc
NASDAQ:BLLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Intrinsic Value
The intrinsic value of BillionToOne Inc (BLLN) under the Base Case is 29.07 USD per share. Compared with the current market price of 114.95 USD, the stock appears Overvalued by 75% .
The intrinsic value is calculated using the DCF method. Net margin recovers from roughly break-even last year to 13% by 2031. Revenue grows about 23% a year over the next five years.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What BillionToOne Does
BillionToOne is a molecular diagnostics company that makes blood-based lab tests for healthcare providers. Its tests are designed to find and measure tiny amounts of genetic material, which helps doctors screen for inherited conditions before birth and detect signs of cancer from a simple blood draw. The company sells these tests to hospitals, clinics, and specialist doctors who need more precise answers than traditional lab work can provide.
- Headquarters
- United States of America US
- Employees
- 713
- IPO date
- Nov 6, 2025
Earnings Waterfall
BillionToOne Inc
What is the Intrinsic Value of one BLLN stock?
The intrinsic value for BillionToOne Inc (BLLN) under the Base Case is 29.07 USD.
Is BLLN stock undervalued or overvalued?
Compared with the current market price of 114.95 USD, the stock appears Overvalued by 75% .